Intrathecal chemotherapy delivered by a lumbar-thecal catheter in metastatic medulloblastoma: a case illustration
First Online: 11 April 2008 Received: 05 March 2008 Accepted: 10 March 2008 DOI:
10.1007/s00701-008-1577-y Cite this article as: Clayton, J., Vloeberghs, M., Jaspan, T. et al. Acta Neurochir (Wien) (2008) 150: 709. doi:10.1007/s00701-008-1577-y Summary Background. Medulloblastoma is the most common malignant brain tumour in children. Despite recent advances, the prognosis in high risk patients remains poor. Further improvement in survival is dependent upon the development of strategies to attack the tumour more effectively, but with less toxicity. Intrathecal chemotherapy, is an ideal but currently underused method of directly targeting residual tumour within the area of resection and the leptomeningeal disease commonly associated with this tumour. Method. We describe the case of a 12 yr old child with metastatic medulloblastoma, who received intrathecal topotecan via a spinal catheter. Conclusion. This method represents a simple, safe and effective method of delivering an even and widespread distribution of drug within the cerebrospinal fluid (CSF) of the neuroaxis. With new agents being identified and others in the early stages of development, intrathecal chemotherapy may emerge as an important therapeutic option to consider when faced with such challenging cases. Keywords: Metastatic medulloblastoma; primitive neuroectodermal tumour; intrathecal chemotherapy; topotecan.
Correspondence: Miss Juliet Clayton, Queens Medical Centre, Department of Neurosurgery, West Block, C Floor, Derby Road, Nottingham NG7 2UH, UK.
References Conroy, S, Craven, I, Garnett, M, Barrat, S, Punt, J, Parker, T, Walker, DA 2004 An extensive review of chemotherapy agents suitable for intrathecal (IT) therapy in primitive neuro ectodermal tumour (PNET) Neuro-oncology 6 428 Dunkel, IJ, Boyett, JM, Yates, A, Rosenblum, M, Garvin, JH, Bostrum, BC, Goldman, S, Sender, LS, Gardner, SL, Li, H, Allen, JC, Finlay, JL 1998 High dose carboplatin, thiotepa and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children’s cancer group J Clin Oncol 16 222 228 PubMed Gajjar, A, Chintagumpala, M, Ashley, D, Kellie, S, Kun, LE, Merchant, TE, Woo, S, Wheeler, G, Ahern, V, Krasin, MJ, Fouladi, M, Broniscer, A, Krance, R, Hale, GA, Stewart, CF, Dauser, R, Sanford, RA, Fuller, C, Lau, C, Boyett, JM, Wallace, D, Gilbertson, RJ 2006 Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long term results from a prospective, multicentre trial Lancet Oncol 10 813 820 CrossRef Gammon, DC, Bhatt, MS, Tran, L, Van Horn, A, Benevenuti, M, Glantz, MJ 2006 Intrathecal topotecan in adult patients with neoplastic meningitis Am J Health-Syst Pharm 63 2083 2086 PubMed CrossRef Kortmann, RD, Kuhl, J, Timmermann, B, Mittler, U, Urban, C, Budach, V, Richter, E, Willich, N, Flentje, M, Berthold, F, Slavc, I, Wolff, J, Meisner, C, Wiestler, O, Sorensen, N, Warmuth-Metz, M, Bamberg, M 2000 Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomised trial HIT’91 Int J Radiat Oncol Biol Phys 46 269 279 PubMed CrossRef Peris-Bonet, R, Martinez-Garcia, C, Lacour, B, Petrovich, S, Giner-Ripoll, B, Navajas, A, Steliarova-Foucher, E 2006 Childhood central nervous system tumours – incidence and survival in Europe (1978–1997): report from automated childhood cancer information system project Eur J Cancer 42 2064 2080 PubMed CrossRef Rood, BR, MacDonald, TJ, Packer, RJ 2004 Current treatment of medulloblastoma: recent advances and future challenges Sem Oncol 31 666 675 CrossRef Rutowski, S, Bode, U, Deinlein, F, Ottensmeier, H, Warmuth-Metz, M, Soerensen, N, Graf, N, Emser, A, Pietsch, T, Wolff, JE, Kortmann, RD, Kuehl, J 2005 Treatment of early childhood medulloblastoma by postoperative chemotherapy alone N Engl J Med 352 978 986 CrossRef Stapleton, S, Blaney, S 2006 New agents for intrathecal adminstration Cancer Invest 24 528 534 PubMed CrossRef Tarbell, NJ, Friedman, HS, Kepner, J, Barnes, P, Burger, P, Kun, LE 2000 Outcome for children with high stage medulloblastoma: results of the Paediatric Oncology Group 9031 study Int J Radiat Oncol Biol Phys 48 179 Taylor, RE, Bailey, CC, Robinson, K, Weston, CL, Ellison, D, Ironside, J, Lucraft, H, Gilbertson, R, Tait, DM, Walker, DA, Pizer, BL, Imeson, J, Lashford, LS 2003 Results of a randomised study of pre-radiation chemotherapy versus radiotherapy alone for non-metastatic (M0-1) medulloblastoma. The international society of Paediatric Oncology/United Kingdom children’s cancer study group PNET-3 study J Clin Oncol 21 1581 1591 PubMed CrossRef Taylor, RE, Bailey, CC, Robinson, KJ, Weston, CL, Walker, DA, Ellison, D, Ironside, J, Pizer, BL, Lashford, LS 2005 Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy Eur J Cancer 41 727 734 PubMed CrossRef Verlooy, J, Mosseri, V, Bracard, S, Lellouch Tubiana, A, Kalifa, C, Pichon, F, Frappaz, D, Chastagner, P, Pagnier, A, Bertozzi, AI, Gentet, JC, Sariban, E, Rialland, X, Edan, C, Bours, D, Zerah, M, Le Gales, C, Alapetite, C, Doz, F 2006 Treatment of high risk medulloblastomas in children above the age of 3 years: A SFOP study Eur J Cancer 42 3004 3014 PubMed CrossRef